About Nanosphere
Nanosphere is a company based in Northbrook (United States) founded in 1999 was acquired by Luminex in May 2016. Nanosphere has raised $97.75 million across 11 funding rounds from investors including NIH, Luminex Corporation and Takara Bio. The company has 146 employees as of December 31, 2016. Nanosphere operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Northbrook, United States
- Employees 146 as on 31 Dec, 2016
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanosphere, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nanosphere
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Sales and Marketing
18 people
Software Development Team
11 people
Finance and Accounting
10 people
Human Resources and Administration
8 people
Corporate Team
4 people
Senior Team
4 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Nanosphere
Nanosphere has successfully raised a total of $97.75M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $970.97 thousand completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nanosphere
Nanosphere has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Luminex Corporation and Takara Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund focused on investing in multiple sectors
|
Locked | Locked | Locked | |
|
Investments and advisory services are provided by the holding company.
|
Locked | Locked | Locked |
Investor details for Nanosphere
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanosphere
Investment portfolio details for Nanosphere
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nanosphere
Detailed financials for Nanosphere
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanosphere Comparisons
Peer comparison for Nanosphere
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanosphere
Nanosphere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| Locked | Locked | Locked |
Diagnostic services are provided through laboratories and radiology units.
|
Detailed competitors of Nanosphere
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanosphere
Complete news archive for Nanosphere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanosphere
Nanosphere was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Nanosphere is headquartered in Northbrook, United States. It is registered at Northbrook, Illinois, United States.
Nanosphere is a funded company, having raised a total of $97.75M across 11 funding rounds to date.
As of Dec 31, 2016, the latest employee count at Nanosphere is 146.
Nanosphere was founded in 1999 and is based in Northbrook, United States. Diagnostic tests for personalized medicine are developed and supplied, with a focus on infections in the bloodstream, respiratory tract, and gastrointestinal tract. The Verigene System is employed, incorporating automation and proprietary chemistry for direct nucleic acid and protein detection on a single platform. All tests are constructed using gold nanoparticle probe technology within the healthcare diagnostics sector.
Nanosphere's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Nanosphere has 10 investors. Key investors include NIH, Luminex Corporation, Takara Bio, Allen & Company, and SWK Holdings.